Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5de92c80d6fa2a1f6b5bdb952875ec01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d675ec9172a9bff6c91127716c76476a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
2000-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3bb8fa87052e2dc1e69695da2f7baf6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37d0b34e38994567f516740baa94fb14 |
publicationDate |
2000-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0068379-A1 |
titleOfInvention |
Methods for treating tumors using antiangiogenic compounds |
abstract |
This invention provides a compound comprising a recombinant nucleic acid encoding an antiangiogenic protein inserted within a viral nucleic acid, wherein the recombinant nucleic acid can be packaged in a virus particle and wherein expression of the recombinant nucleic acid encoding the antiangiogenic protein results in production of the antiangiogenic protein. The present invention also provides a method of delivering an antiangiogenic protein to a cell, delivering an antiangiogenic protein to a subject, and treating a tumor in a subject comprising administering a virus comprising a recombinant nucleic acid encoding an antiangiogenic protein inserted within the viral nucleic acid, wherein the recombinant nucleic acid can be packaged in a virus particle, and wherein expression of the recombinant nucleic acid encoding the antiangiogenic protein results in production of the antiangiogenic protein, thereby delivering the antiangiogenic protein to the cell. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110664996-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110664996-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0112830-A1 |
priorityDate |
1999-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |